IART logo

IART Cash from financing

annual CFF:

$237.86M+$467.79M(+203.45%)
December 31, 2024

Summary

  • As of today (September 19, 2025), IART annual cash flow from financing activities is $237.86 million, with the most recent change of +$467.79 million (+203.45%) on December 31, 2024.
  • During the last 3 years, IART annual CFF has risen by +$336.09 million (+342.16%).
  • IART annual CFF is now -79.65% below its all-time high of $1.17 billion, reached on December 31, 2017.

Performance

IART Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIARTcash flow metrics

quarterly CFF:

-$21.14M-$56.52M(-159.75%)
June 30, 2025

Summary

  • As of today (September 19, 2025), IART quarterly cash flow from financing activities is -$21.14 million, with the most recent change of -$56.52 million (-159.75%) on June 30, 2025.
  • Over the past year, IART quarterly CFF has increased by +$72.61 million (+77.45%).
  • IART quarterly CFF is now -103.18% below its all-time high of $664.21 million, reached on December 31, 2017.

Performance

IART quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIARTcash flow metrics

TTM CFF:

-$12.83M+$72.61M(+84.99%)
June 30, 2025

Summary

  • As of today (September 19, 2025), IART TTM cash flow from financing activities is -$12.83 million, with the most recent change of +$72.61 million (+84.99%) on June 30, 2025.
  • Over the past year, IART TTM CFF has dropped by -$221.21 million (-106.16%).
  • IART TTM CFF is now -101.10% below its all-time high of $1.17 billion, reached on December 31, 2017.

Performance

IART TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIARTcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

IART Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+203.4%+77.5%-106.2%
3 y3 years+342.2%-60.8%+91.1%
5 y5 years+2813.5%+26.0%-109.7%

IART Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+194.4%-105.9%+87.0%-104.4%+96.0%
5 y5-yearat high+194.4%-105.9%+87.0%-104.4%+96.0%
alltimeall time-79.7%+194.4%-103.2%+87.0%-101.1%+96.0%

IART Cash from financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$21.14M(-159.8%)
-$12.83M(-85.0%)
Mar 2025
-
$35.38M(-594.8%)
-$85.44M(-135.9%)
Dec 2024
$237.86M(-203.5%)
-$7.15M(-64.1%)
$237.86M(-0.1%)
Sep 2024
-
-$19.91M(-78.8%)
$238.12M(+14.3%)
Jun 2024
-
-$93.75M(-126.1%)
$208.38M(-28.5%)
Mar 2024
-
$358.68M(-5305.7%)
$291.43M(-226.8%)
Dec 2023
-$229.93M(-8.7%)
-$6.89M(-86.1%)
-$229.93M(-28.3%)
Sep 2023
-
-$49.66M(+364.4%)
-$320.73M(+15.1%)
Jun 2023
-
-$10.69M(-93.4%)
-$278.72M(-0.9%)
Mar 2023
-
-$162.68M(+66.5%)
-$281.17M(+11.6%)
Dec 2022
-$251.95M(+156.5%)
-$97.70M(+1178.4%)
-$251.95M(+63.9%)
Sep 2022
-
-$7.64M(-41.9%)
-$153.73M(+6.5%)
Jun 2022
-
-$13.15M(-90.1%)
-$144.35M(-36.9%)
Mar 2022
-
-$133.47M(<-9900.0%)
-$228.68M(+132.8%)
Dec 2021
-$98.23M(-180.8%)
$521.00K(-70.1%)
-$98.23M(+26.7%)
Sep 2021
-
$1.74M(-101.8%)
-$77.53M(-31.0%)
Jun 2021
-
-$97.47M(+3133.0%)
-$112.32M(+158.8%)
Mar 2021
-
-$3.02M(-114.2%)
-$43.40M(-135.7%)
Dec 2020
$121.63M(-1487.5%)
$21.22M(-164.2%)
$121.63M(+560.6%)
Sep 2020
-
-$33.05M(+15.7%)
$18.41M(-86.1%)
Jun 2020
-
-$28.55M(-117.6%)
$132.49M(-10.4%)
Mar 2020
-
$162.00M(-297.6%)
$147.85M(-1786.6%)
Dec 2019
-$8.77M(-95.2%)
-$81.99M(-201.2%)
-$8.77M(+51.3%)
Sep 2019
-
$81.03M(-714.2%)
-$5.79M(-95.4%)
Jun 2019
-
-$13.19M(-344.6%)
-$126.66M(-15.3%)
Mar 2019
-
$5.39M(-106.8%)
-$149.56M(-14.9%)
Dec 2018
-$180.87M(-115.5%)
-$79.02M(+98.3%)
-$175.84M(-131.0%)
Sep 2018
-
-$39.84M(+10.4%)
$567.40M(-36.5%)
Jun 2018
-
-$36.09M(+72.8%)
$893.61M(-7.2%)
Mar 2018
-
-$20.89M(-103.1%)
$963.02M(-17.6%)
Dec 2017
$1.17B(-7833.2%)
$664.21M(+131.9%)
$1.17B(+125.4%)
Sep 2017
-
$286.37M(+759.4%)
$518.50M(+144.2%)
Jun 2017
-
$33.32M(-82.0%)
$212.33M(+25.0%)
Mar 2017
-
$185.04M(+1244.5%)
$169.92M(-1224.1%)
Dec 2016
-$15.12M(-106.1%)
$13.76M(-169.5%)
-$15.12M(-73.4%)
Sep 2016
-
-$19.80M(+118.0%)
-$56.76M(-127.2%)
Jun 2016
-
-$9.08M(<-9900.0%)
$208.61M(-20.4%)
Mar 2016
-
$0.00(-100.0%)
$261.97M(+5.6%)
Dec 2015
$248.14M(+4.0%)
-$27.88M(-111.4%)
$248.14M(-13.8%)
Sep 2015
-
$245.57M(+454.6%)
$287.76M(+892.4%)
Jun 2015
-
$44.28M(-420.2%)
$29.00M(-304.0%)
Mar 2015
-
-$13.83M(-217.8%)
-$14.22M(-105.9%)
Dec 2014
$238.68M(+1155.0%)
$11.74M(-189.0%)
$242.78M(+5.3%)
Sep 2014
-
-$13.19M(-1342.2%)
$230.56M(-5.5%)
Jun 2014
-
$1.06M(-99.6%)
$243.93M(-6.9%)
Mar 2014
-
$243.17M(<-9900.0%)
$261.94M(+1277.2%)
Dec 2013
$19.02M(+61.9%)
-$488.00K(-365.2%)
$19.02M(-16.2%)
Sep 2013
-
$184.00K(-99.0%)
$22.71M(-1.2%)
Jun 2013
-
$19.07M(+7318.7%)
$22.98M(-7.9%)
Mar 2013
-
$257.00K(-92.0%)
$24.95M(+105.6%)
Dec 2012
$11.75M(-80.5%)
$3.20M(+596.1%)
$12.13M(+35.8%)
Sep 2012
-
$460.00K(-97.8%)
$8.93M(-80.1%)
Jun 2012
-
$21.03M(-267.5%)
$44.85M(-62.4%)
Mar 2012
-
-$12.56M(-134.5%)
$119.14M(-5.4%)
Dec 2011
$60.14M(-3920.6%)
-
-
Sep 2011
-
$36.38M(-61.8%)
$125.92M(+139.7%)
Jun 2011
-
$95.32M(-314.4%)
$52.54M(-243.7%)
Mar 2011
-
-$44.45M(-214.9%)
-$36.56M(+2223.1%)
Dec 2010
-$1.57M
$38.67M(-204.5%)
-$1.57M(-97.1%)
DateAnnualQuarterlyTTM
Sep 2010
-
-$37.00M(-694.9%)
-$53.36M(-24.2%)
Jun 2010
-
$6.22M(-165.7%)
-$70.37M(-54.0%)
Mar 2010
-
-$9.46M(-27.8%)
-$152.85M(-10.8%)
Dec 2009
-$171.34M(-211.6%)
-$13.11M(-75.7%)
-$171.34M(+79.1%)
Sep 2009
-
-$54.01M(-29.2%)
-$95.69M(-314.6%)
Jun 2009
-
-$76.26M(+172.8%)
$44.59M(+873.9%)
Mar 2009
-
-$27.96M(-144.7%)
$4.58M(-97.0%)
Dec 2008
$153.54M(+41.5%)
$62.54M(-27.5%)
$153.54M(+109.7%)
Sep 2008
-
$86.27M(-174.2%)
$73.20M(-949.1%)
Jun 2008
-
-$116.27M(-196.1%)
-$8.62M(-103.7%)
Mar 2008
-
$121.00M(-780.0%)
$232.85M(+114.6%)
Dec 2007
$108.48M(+137.7%)
-$17.79M(-500.4%)
$108.48M(+0.1%)
Sep 2007
-
$4.44M(-96.5%)
$108.32M(-2.4%)
Jun 2007
-
$125.20M(-3821.7%)
$110.97M(+421.9%)
Mar 2007
-
-$3.36M(-81.3%)
$21.26M(-53.4%)
Dec 2006
$45.64M(-194.4%)
-$17.96M(-353.2%)
$45.64M(+31.1%)
Sep 2006
-
$7.09M(-80.0%)
$34.81M(+20.1%)
Jun 2006
-
$35.49M(+68.9%)
$28.99M(-197.9%)
Mar 2006
-
$21.01M(-173.0%)
-$29.60M(-38.8%)
Dec 2005
-$48.34M(+495.6%)
-$28.78M(-2368.2%)
-$48.34M(+174.3%)
Sep 2005
-
$1.27M(-105.5%)
-$17.62M(-45.7%)
Jun 2005
-
-$23.10M(-1113.2%)
-$32.44M(+358.7%)
Mar 2005
-
$2.28M(+18.2%)
-$7.07M(-12.9%)
Dec 2004
-$8.12M(-108.6%)
$1.93M(-114.2%)
-$8.12M(+80.9%)
Sep 2004
-
-$13.55M(-697.8%)
-$4.49M(-143.3%)
Jun 2004
-
$2.27M(+83.3%)
$10.37M(-61.8%)
Mar 2004
-
$1.24M(-77.8%)
$27.17M(-71.3%)
Dec 2003
$94.67M(-4745.4%)
$5.56M(+323.9%)
$94.67M(+6.7%)
Sep 2003
-
$1.31M(-93.1%)
$88.73M(+1.0%)
Jun 2003
-
$19.07M(-72.3%)
$87.89M(+26.8%)
Mar 2003
-
$68.74M(<-9900.0%)
$69.33M(-3501.7%)
Dec 2002
-$2.04M(-101.9%)
-$389.00K(-182.6%)
-$2.04M(-207.7%)
Sep 2002
-
$471.00K(-6.7%)
$1.89M(-98.2%)
Jun 2002
-
$505.00K(-119.2%)
$106.80M(+0.0%)
Mar 2002
-
-$2.63M(-174.1%)
$106.79M(-2.4%)
Dec 2001
$109.46M(+666.9%)
$3.54M(-96.6%)
$109.46M(+2.4%)
Sep 2001
-
$105.38M(>+9900.0%)
$106.93M(+1215.1%)
Jun 2001
-
$498.00K(+1176.9%)
$8.13M(-0.6%)
Mar 2001
-
$39.00K(-96.2%)
$8.18M(-42.7%)
Dec 2000
$14.27M(+27.9%)
$1.01M(-84.6%)
$14.27M(-5.3%)
Sep 2000
-
$6.58M(+1100.7%)
$15.07M(+81.3%)
Jun 2000
-
$548.00K(-91.1%)
$8.31M(+13.8%)
Mar 2000
-
$6.13M(+238.3%)
$7.31M(-34.5%)
Dec 1999
$11.16M(+196.6%)
$1.81M(-1129.5%)
$11.16M(+19.1%)
Sep 1999
-
-$176.00K(-61.6%)
$9.37M(+0.0%)
Jun 1999
-
-$458.00K(-104.6%)
$9.37M(-31.8%)
Mar 1999
-
$9.98M(>+9900.0%)
$13.74M(+265.2%)
Dec 1998
$3.76M(+840.5%)
$20.00K(-111.3%)
$3.76M(-2.1%)
Sep 1998
-
-$177.00K(-104.5%)
$3.84M(-4.4%)
Jun 1998
-
$3.92M(>+9900.0%)
$4.02M(+3764.4%)
Mar 1998
-
$4000.00(-96.0%)
$104.00K(-74.0%)
Dec 1997
$400.00K(-98.9%)
$100.00K(>+9900.0%)
$400.00K(+33.3%)
Sep 1997
-
$0.00(0.0%)
$300.00K(+50.0%)
Jun 1997
-
$0.00(-100.0%)
$200.00K(-50.0%)
Mar 1997
-
$300.00K(>+9900.0%)
$400.00K(-98.9%)
Dec 1996
$36.50M(+5114.3%)
$0.00(-100.0%)
$36.50M(0.0%)
Sep 1996
-
-$100.00K(-150.0%)
$36.50M(-0.3%)
Jun 1996
-
$200.00K(-99.5%)
$36.60M(+0.5%)
Mar 1996
-
$36.40M
$36.40M
Dec 1995
$700.00K
-
-

FAQ

  • What is Integra LifeSciences Holdings Corporation annual cash flow from financing activities?
  • What is the all time high annual CFF for Integra LifeSciences Holdings Corporation?
  • What is Integra LifeSciences Holdings Corporation annual CFF year-on-year change?
  • What is Integra LifeSciences Holdings Corporation quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Integra LifeSciences Holdings Corporation?
  • What is Integra LifeSciences Holdings Corporation quarterly CFF year-on-year change?
  • What is Integra LifeSciences Holdings Corporation TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Integra LifeSciences Holdings Corporation?
  • What is Integra LifeSciences Holdings Corporation TTM CFF year-on-year change?

What is Integra LifeSciences Holdings Corporation annual cash flow from financing activities?

The current annual CFF of IART is $237.86M

What is the all time high annual CFF for Integra LifeSciences Holdings Corporation?

Integra LifeSciences Holdings Corporation all-time high annual cash flow from financing activities is $1.17B

What is Integra LifeSciences Holdings Corporation annual CFF year-on-year change?

Over the past year, IART annual cash flow from financing activities has changed by +$467.79M (+203.45%)

What is Integra LifeSciences Holdings Corporation quarterly cash flow from financing activities?

The current quarterly CFF of IART is -$21.14M

What is the all time high quarterly CFF for Integra LifeSciences Holdings Corporation?

Integra LifeSciences Holdings Corporation all-time high quarterly cash flow from financing activities is $664.21M

What is Integra LifeSciences Holdings Corporation quarterly CFF year-on-year change?

Over the past year, IART quarterly cash flow from financing activities has changed by +$72.61M (+77.45%)

What is Integra LifeSciences Holdings Corporation TTM cash flow from financing activities?

The current TTM CFF of IART is -$12.83M

What is the all time high TTM CFF for Integra LifeSciences Holdings Corporation?

Integra LifeSciences Holdings Corporation all-time high TTM cash flow from financing activities is $1.17B

What is Integra LifeSciences Holdings Corporation TTM CFF year-on-year change?

Over the past year, IART TTM cash flow from financing activities has changed by -$221.21M (-106.16%)
On this page